Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer : A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group
(2020) In Pediatric Blood and Cancer 67(12).- Abstract
Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/97b29de9-69be-4e25-877c-08db1fac4494
- author
- organization
- publishing date
- 2020-12
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- childhood adolescent and young adult (CAYA) cancer survivors, COVID-19, late effects of cancer treatment
- in
- Pediatric Blood and Cancer
- volume
- 67
- issue
- 12
- article number
- e28702
- publisher
- John Wiley & Sons Inc.
- external identifiers
-
- scopus:85091359946
- pmid:32969160
- ISSN
- 1545-5009
- DOI
- 10.1002/pbc.28702
- language
- English
- LU publication?
- yes
- id
- 97b29de9-69be-4e25-877c-08db1fac4494
- date added to LUP
- 2020-10-27 11:47:16
- date last changed
- 2025-06-13 08:43:50
@article{97b29de9-69be-4e25-877c-08db1fac4494,
abstract = {{<p>Childhood, adolescent, and young adult (CAYA) cancer survivors may be at risk for a severe course of COVID-19. Little is known about the clinical course of COVID-19 in CAYA cancer survivors, or if additional preventive measures are warranted. We established a working group within the International Late Effects of Childhood Cancer Guideline Harmonization Group (IGHG) to summarize existing evidence and worldwide recommendations regarding evidence about factors/conditions associated with risk for a severe course of COVID-19 in CAYA cancer survivors, and to develop a consensus statement to provide guidance for healthcare practitioners and CAYA cancer survivors regarding COVID-19.</p>}},
author = {{Verbruggen, Lisanne C. and Wang, Yuehan and Armenian, Saro H. and Ehrhardt, Matthew J. and van der Pal, Helena J.H. and van Dalen, Elvira C. and van As, Jorrit W. and Bardi, Edit and Baust, Katja and Berger, Claire and Castagnola, Elio and Devine, Katie A. and Gebauer, Judith and Marchak, Jordan Gilleland and Glaser, Adam W. and Groll, Andreas H. and Haeusler, Gabrielle M. and den Hartogh, Jaap and Haupt, Riccardo and Hjorth, Lars and Kato, Miho and Kepák, Tomáš and Koopman, Maria M.W. and Langer, Thorsten and Maeda, Miho and Michel, Gisela and Muraca, Monica and Nathan, Paul C. and van den Oever, Selina R. and Pavasovic, Vesna and Sato, Satomi and Schulte, Fiona and Sung, Lillian and Tissing, Wim and Uyttebroeck, Anne and Mulder, Renée L. and Kuehni, Claudia and Skinner, Roderick and Hudson, Melissa M. and Kremer, Leontien C.M.}},
issn = {{1545-5009}},
keywords = {{childhood adolescent and young adult (CAYA) cancer survivors; COVID-19; late effects of cancer treatment}},
language = {{eng}},
number = {{12}},
publisher = {{John Wiley & Sons Inc.}},
series = {{Pediatric Blood and Cancer}},
title = {{Guidance regarding COVID-19 for survivors of childhood, adolescent, and young adult cancer : A statement from the International Late Effects of Childhood Cancer Guideline Harmonization Group}},
url = {{http://dx.doi.org/10.1002/pbc.28702}},
doi = {{10.1002/pbc.28702}},
volume = {{67}},
year = {{2020}},
}